two new biotech drugs for colorectal cancer, Avastin and Erbitux
March 2004
You might hear about two new biotech drugs for colorectal cancer, Avastin and Erbitux.
They just got approved in the U.S...investigational in Canada.
Avastin (bevacizumab) is the first angiogenesis inhibitor. It's plowing new ground for the new crop of cancer drugs that slow the growth of new blood vessels that tumours need to grow.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive